论文部分内容阅读
Objective Hepatocellular carcinoma(HCC),one of the most common primary liver cancers,represents approximately 75%-85%of cases and constitutes a major global health problem with the highest incidence rates in East Asia.It is urgent to identify effective biomarkers and therapeutic targets for the treatment of HCC.